Skip to content

Respimat

by Boehringer Ingelheim Pharma GmbH & Co. KG Germany EUDAMED

Ref INH RES A5.9.1 R Olodaterol / 87029 EMDN R03010302

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number4065477RESPIMATEJ Basic UDI-DIDate3 Dec 2024RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 25 Oct 2026

Model / Reference
INH RES A5.9.1 R Olodaterol / 87029
Primary DI / UDI-DI
04065477001079
Basic UDI-DI
4065477RESPIMATEJ
Direct Marketing DI
04065477001079
EMDN Code
R03010302 Aerosol portable inhalers
Device Class
Class IIb
Market of Registration
Netherlands

Manufacturer details

EUDAMED SRN
DE-MF-000015595

Other devices from Boehringer Ingelheim Pharma GmbH & Co. KG

Properties & raw data

Show properties, registry sources and raw records
  • Administering Medicine
Other properties (12)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 3405f532-7ea3-40bc-8468-126e8ad741f5 61 fields · synced 25 Oct 2026